BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 31659558)

  • 1. Fabrication of Ibrutinib Nanosuspension by Quality by Design  Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability.
    Rangaraj N; Pailla SR; Chowta P; Sampathi S
    AAPS PharmSciTech; 2019 Oct; 20(8):326. PubMed ID: 31659558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability.
    Rahim H; Sadiq A; Ullah R; Bari A; Amin F; Farooq U; Ullah Jan N; Mahmood HM
    Int J Nanomedicine; 2020; 15():8999-9009. PubMed ID: 33235448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpetetrone nanosuspensions enhance drug solubility and bioavailability to improve anti-hepatic fibrosis effects.
    Zhong Y; Hang L; Wang F; Shen B; Shen C; Xue Y; Jia H; Wang L; Yuan H
    J Microencapsul; 2023 Dec; 40(8):587-598. PubMed ID: 37733492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization and antitumor activity evaluation of apigenin nanoparticles by the liquid antisolvent precipitation technique.
    Wu W; Zu Y; Wang L; Wang L; Wang H; Li Y; Wu M; Zhao X; Fu Y
    Drug Deliv; 2017 Nov; 24(1):1713-1720. PubMed ID: 29115900
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Shariare MH; Altamimi MA; Marzan AL; Tabassum R; Jahan B; Reza HM; Rahman M; Ahsan GU; Kazi M
    Saudi Pharm J; 2019 Jan; 27(1):96-105. PubMed ID: 30662312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and
    Mujtaba MA; Kaleem M; Chaware R; Ingole A; Asiri YI; Hassan MZ; Sabale V; Sabale P; Anwer MK; Mahmood D; Aldawsari MF
    ACS Omega; 2024 Apr; 9(14):16346-16357. PubMed ID: 38617636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs.
    Elsebay MT; Eissa NG; Balata GF; Kamal MA; Elnahas HM
    Curr Pharm Des; 2023; 29(29):2297-2312. PubMed ID: 37694786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach.
    Kuk DH; Ha ES; Ha DH; Sim WY; Lee SK; Jeong JS; Kim JS; Baek IH; Park H; Choi DH; Yoo JW; Jeong SH; Hwang SJ; Kim MS
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31861173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-driven entrapment of enrofloxacin in casein-based nanoparticles for the enhancement of oral bioavailability.
    Yuan ZX; Deng S; Chen L; Hu Y; Gu J; He L
    Food Sci Nutr; 2021 Aug; 9(8):4057-4067. PubMed ID: 34401057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FABRICATION AND EVALUATION OF SMART NANOCRYSTALS OF ARTEMISININ FOR ANTIMALARIAL AND ANTIBACTERIAL EFFICACY.
    Shah SMH; Ullah F; Khan S; Shah SMM; Isreb M
    Afr J Tradit Complement Altern Med; 2017; 14(1):251-262. PubMed ID: 28480403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and
    Khanuja HK; Awasthi R; Dureja H
    J Chemother; 2023 Oct; ():1-20. PubMed ID: 37881008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tannic acid coated nanosuspension for oral delivery of chrysin intended for anti-schizophrenic effect in mice.
    Salama A; Hamed Salama A; Hasanein Asfour M
    Int J Pharm; 2024 May; 656():124085. PubMed ID: 38580073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term antitrypanosomal effect of quinapyramine sulphate-loaded oil-based nanosuspension in T. evansi-infected mouse model.
    Prayag KS; Paul AT; Ghorui SK; Jindal AB
    Drug Deliv Transl Res; 2024 Feb; 14(2):542-554. PubMed ID: 37648938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation.
    Nakarani M; Patel P; Patel J; Patel P; Murthy RS; Vaghani SS
    Sci Pharm; 2010; 78(2):345-61. PubMed ID: 21179351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The improvement of tyrosol bioavailability by encapsulation into liposomes using pH-driven method.
    Yao Y; Ma L; Yu C; Cheng C; Gao H; Wei T; Li L; Wang Z; Liu W; Deng Z; Zou L; Luo T
    Food Chem; 2024 Jul; 445():138661. PubMed ID: 38350195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Anti-Inflammatory Activity of Tilianin Based on the Novel Amorphous Nanocrystals.
    Sun M; Guo M; He Z; Luo Y; He X; Huang C; Yuan Y; Zhao Y; Song X; Wang X
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and Comprehensive Evaluation of the Efficacy and Safety of Chlorantraniliprole Nanosuspension.
    Ding X; Guo L; Du Q; Wang T; Zeng Z; Wang Y; Cui H; Gao F; Cui B
    Toxics; 2024 Jan; 12(1):. PubMed ID: 38251033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The investigation of parameters affecting Ibrutinib release from chitosan/tripolyphosphate/carbon nanofiber composite microspheres.
    Armutcu C
    Turk J Chem; 2022; 46(5):1632-1641. PubMed ID: 37529729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension.
    Sampathi S; Prajapati S; Junnuthula V; Dyawanapelly S
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects.
    Rangaraj N; Sampathi S; Junnuthula V; Kolimi P; Mandati P; Narala S; Nyavanandi D; Dyawanapelly S
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.